Immediate Impact
34 standout
Citing Papers
Targeting ROS in cancer: rationale and strategies
2024 Standout
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Works of Jianglong Lu being referenced
Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling
2021
Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jianglong Lu | 172 | 17 | 46 | 84 | 47 | 27 | 293 | |
| Mariana Fuertes | 131 | 16 | 102 | 86 | 54 | 18 | 288 | |
| Suyue Zheng | 149 | 57 | 28 | 94 | 39 | 20 | 306 | |
| Fulvio D’Angelo | 151 | 10 | 22 | 84 | 41 | 22 | 334 | |
| Yuxue Sun | 135 | 33 | 34 | 42 | 77 | 23 | 333 | |
| Ranran Shi | 124 | 7 | 31 | 68 | 21 | 24 | 297 | |
| Heng Zhang | 110 | 21 | 19 | 45 | 59 | 35 | 321 | |
| Yu Q | 140 | 6 | 51 | 62 | 34 | 46 | 292 | |
| Feng Cai | 121 | 20 | 103 | 59 | 60 | 28 | 330 | |
| Zhangqi Dou | 134 | 56 | 17 | 64 | 36 | 20 | 292 | |
| Weiping Li | 180 | 33 | 22 | 43 | 18 | 25 | 322 |
All Works
Login with ORCID to disown or claim papers
Loading papers...